In this study, we explored the potential use of microglia engineered to express IL-15 upon infection with a recombinant adeno-associated virus serotype 2 (rAAV2) carrying IL-15 (rAAV2-IL-15), to simulate the effect of EE on glioma. Here, IL15 is linked to infection.